+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
From
From
From
From
From
Gastric Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Gastric Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Head and Neck Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Nasopharyngeal Carcinoma Treatment Global Market Report 2024 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Checkpoint Inhibitors Global Market Report 2024 - Product Thumbnail Image

Checkpoint Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Global Market Report 2024 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Sarcoma Drugs Global Market Report 2024 - Product Thumbnail Image

Sarcoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Solid Tumor Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Solid Tumor Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more